TransDigm TDG 深 滬
等待開盤 11-26 09:30:00 美东时间
1352.54
+16.780
+1.26%
華盛通- 最 高1362.05
- 今 開1338.78
- 成交量 28.39万股
- 最 低 1331.94
- 昨 收 1335.76
- 總市值 761.73亿
- 52周最高 1533.825
- 市盈率 靜 42.19
- 換手率 0.50%
- 52周最低 1093.60
- 委 比 -60.00%
- 總股本 5631.86万
- 歷史最高 1533.825
- 量 比 0.82
- 振 幅 2.25%
- 歷史最低 -278.24
- 每 手 1
- 風險率 83.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Northrop Grumman awarded $100M U.S. Air Force contract
Northrop Grumman (NOC) has been awarded a ceiling $100M U.S. Air Force contract. This contract provides for active seeker specific support associated for components, test and evaluation support, scie...
今天 06:22
Defense stocks slide on signs of possible Ukraine-Russia peace progress
Aerospace and defense shares came under pressure Monday as President Donald Trump suggested that diplomatic efforts to end the war in Ukraine may be gaining traction, a comment that investors interpre...
11-25 03:39
Boeing Starliner missions for NASA scaled back after failed test flight
NASA scaled back its plans for Boeing’s (BA) Starliner capsule, reducing the number of scheduled trips to the International Space Station after last year’s troubled test mission and as the ISS approac...
11-25 03:15
AeroVironment rated Overweight in new coverage at Piper Sandler
Piper Sandler late Wednesday launched coverage of AeroVironment (AVAV) with an Overweight rating, arguing that the drone-technology company is evolving into a diversified defense platform poised for “...
11-21 01:54
RTX, TransDigm, AeroVironment lead BNP Paribas’ bullish new calls on U.S. aerospace & defense
BNP Paribas Exane on Wednesday initiated coverage of a dozen U.S. aerospace and defense companies, arguing that investors should be selective as commercial aerospace faces tougher comparisons while de...
11-20 03:13
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
UBS Maintains Buy on TransDigm Gr, Raises Price Target to $1798
UBS analyst Gavin Parsons maintains TransDigm Gr (NYSE:TDG) with a Buy and raises the price target from $1738 to $1798.
11-13 23:13
财报速睇 | TransDigm Group INC 2025财年年度营收88.31亿美元，股权持有人应占溢利18.66亿美元
华盛资讯11月13日讯，TransDigm Group INC公司今日公布2025财年年度业绩，公司年度营收88.31亿美元，同比增长11.2%，股权持有人应占溢利18.66亿美元，同比增长26.0%。
11-13 05:32
Transdigm Group Reports Strong OEM, Aftermarket And Defense Market Growth In Q4
TransDigm (TDG) beats Q4 FY25 estimates with $2.44B in sales, EPS of $10.82, strong aftermarket and defense growth, and a $5.2B special dividend payout.
11-12 22:56
